CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus. Hybel TE, Vase MO, Lauridsen KL, Enemark MB, et al. Leuk Lymphoma 2022 Jan 12:1-5. doi: 10.1080/10428194.2021.2023741.

Read + Share

Amedeo Smart

Independent Medical Education

Hybel TE, Vase MO, Lauridsen KL, Enemark MB, et al. CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus. Leuk Lymphoma 2022 Jan 12:1-5. doi: 10.1080/10428194.2021.2023741.
PMID: 35019824